| Pfizer AG - Lorviqua 25 mg, Filmtabletten | | 66941 | | 01 | | Lorviqua 25 mg | | Filmtabletten | | L01ED05 | | Lorlatinib | | 19.02.2020 | | |
| | Composition | | lorlatinibum 25 mg, cellulosum microcristallinum, calcii hydrogenophosphas dihydricus, carboxymethylamylum natricum A corresp. natrium 0.315 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 1.575 mg, macrogolum 4000, triacetinum, E 171, E 172 (nigrum), E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Lorlatinibum | 25 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Lorlatinibum | 25 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Nigrum) | | | | (Rubrum) | | | | Calcium Hydrogenophosphate Dihydrate | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 1.575 mg | | | Macrogol | 4000 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Triacetinum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 003 | 90 | 3288.55 | 3592.90 | A | LS | Non |
|
|
